ORCID as entered in ROS
https://orcid.org/0000-0001-5606-0270
Select Publications
Journal articles
, 2012, 'Cutaneous sarcoidosis in a patient with ulcerative colitis on infliximab', Journal of Crohn's and Colitis, 2012, pp. 708 - 712, http://dx.doi.org/10.1016/j.crohns.2012.01.008
, 2012, 'P331 Role of infliximab as rescue therapy in hospitalised patients with severe, steroid refractory ulcerative colitis. Local experience. Liverpool and Bankstown hospitals, South Western Sydney Local Health District. Australia', Journal of Crohn's and Colitis, 6, pp. S141 - S142, http://dx.doi.org/10.1016/s1873-9946(12)60351-1
, 2012, 'Targeted metabolomics identifies perturbations in amino acid metabolism that sub-classify patients with COPD', MOLECULAR BIOSYSTEMS, 8, pp. 3125 - 3133, http://dx.doi.org/10.1039/c2mb25194a
, 2011, 'How to treat', Australian Doctor, pp. 27 - 34
, 2010, 'Knowledge, perception and practices of colorectal cancer screening in an ethnically diverse population', Cancer Epidemiology, 34, pp. 604 - 610, http://dx.doi.org/10.1016/j.canep.2010.05.013
, 2009, 'Colorectal cancer screening practice is influenced by ethnicity of patient and general practitioner', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 24, pp. A224 - A224, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270551200012&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2008, 'Clinical and pathologic outcomes of colorectal cancer in a multi-ethnic population', Clinical Gastroenterology and Hepatology, 6, pp. 1016 - 1021
, 2008, 'Improved survival in young women with colorectal cancer', American Journal of Gastroenterology, 103, pp. 1488 - 1495, http://dx.doi.org/10.1111/j.1572-0241.2007.01779.x
, 2006, 'Managing inflammatory bowel disease', Medicine Today, 7, pp. 14 - 23
, 2005, 'Vasoactive intestinal peptide impairs leucocyte migration but fails to modify experimental murine colitis', Clinical and Experimental Immunology, 139, pp. 411 - 420
, 2004, 'CCR2 expressing CD4+ T lymphocytes are preferentially recruited to the ileum in Crohn's disease (vol 53, pg 1287, 2004)', GUT, 53, pp. 1722 - 1722, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000224407200042&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2004, 'CCR2 expressing CD4+T lymphocytes are preferentially recruited to the ileum in Crohn's disease', Gut, 53, pp. 1287 - 1294
, 2003, 'Cutting Edge: Vasoactive Intestinal Peptide Acts as a Potent Suppressor of Inflammation In Vivo by Trans-Deactivating Chemokine Receptors', Journal of Immunology, 171, pp. 4990 - 4994, http://dx.doi.org/10.4049/jimmunol.171.10.4990
, 2001, 'Heparin as an anti-inflammatory agent: It's no GAG to forget about chemokines [3]', Gut, 48, pp. 738, http://dx.doi.org/10.1136/gut.48.5.738
, 2001, 'AMELIORATION OF MURINE TNBS COLITIS USING PREBIOTICS', Journal of Gastroenterology and Hepatology, 16, pp. 6 - 6, http://dx.doi.org/10.1111/j.1440-1746.2001.ca01-6.x
, 2001, 'Amelioration of TNBS colitis in mice using preblotics', Gastroenterology, 120, pp. A82 - A82, http://dx.doi.org/10.1016/s0016-5085(08)80404-0
, 1999, 'The effect of dosing with omeprazole on the accuracy of the 13C-urea breath test in Helicobacter pylori-infected subjects', Alimentary Pharmacology and Therapeutics, 13, pp. 1287 - 1293, http://dx.doi.org/10.1046/j.1365-2036.1999.00601.x
, 1999, 'The impact of short-term ranitidine use on the precision of the 13C-urea breath test in subjects infected with Helicobacter pylori', European Journal of Gastroenterology and Hepatology, 11, pp. 1135 - 1138, http://dx.doi.org/10.1097/00042737-199910000-00010
, 1998, 'Perianal Paget's disease: a histologic and immunohistochemical study of 11 cases with and without associated rectal adenocarcinoma.', Am J Surg Pathol, 22, pp. 170 - 179, http://dx.doi.org/10.1097/00000478-199802000-00004
, 1997, 'A case of upper gastrointestinal bleeding secondary to a bread bag clip', Australian and New Zealand Journal of Medicine, 27, pp. 75, http://dx.doi.org/10.1111/j.1445-5994.1997.tb00918.x
, 1992, 'In vitro hydrogen production by enteric bacteria cultured from children with small bowel bacterial overgrowth', Journal of Pediatric Gastroenterology and Nutrition, 14, pp. 192 - 197, http://dx.doi.org/10.1097/00005176-199202000-00013
, 1992, 'In Vitro Hydrogen Production by Enteric Bacteria Cultured from Children with Small Bowel Bacterial Overgrowth', Journal of Pediatric Gastroenterology and Nutrition, 14, pp. 192 - 197, http://dx.doi.org/10.1002/j.1536-4801.1992.tb10524.x
, 1985, 'EFFECTS OF TURBIDITY ON CALCIFICATION RATE, PROTEIN-CONCENTRATION AND THE FREE AMINO-ACID POOL OF THE CORAL ACROPORA-CERVICORNIS', MARINE BIOLOGY, 87, pp. 33 - 46, http://dx.doi.org/10.1007/BF00397003
, 1984, 'EFFECT OF 8 OUTER CONTINENTAL-SHELF DRILLING MUDS ON THE CALCIFICATION RATE AND FREE AMINO-ACID POOL OF THE CORAL ACROPORA-CERVICORNIS', BULLETIN OF ENVIRONMENTAL CONTAMINATION AND TOXICOLOGY, 33, pp. 362 - 372, http://dx.doi.org/10.1007/BF01625556
, 1984, 'RECOVERY BY THE CORAL ACROPORA-CERVICORNIS AFTER DRILLING MUD EXPOSURE - THE FREE AMINO-ACID POOL', ARCHIVES OF ENVIRONMENTAL CONTAMINATION AND TOXICOLOGY, 13, pp. 243 - 258, http://dx.doi.org/10.1007/BF01055883
, 1984, 'THE IMPORTANCE OF MONITORING METABOLIC RECOVERY IN THE CORAL ACROPORA-CERVICORNIS AFTER SHORT-TERM EXPOSURE TO DRILLING MUDS - CALCIFICATION RATE AND PROTEIN-CONCENTRATION', CORAL REEFS, 2, pp. 215 - 225
, 1983, 'THE EFFECTS OF DRILLING-FLUIDS (MUDS) AND TURBIDITY ON THE GROWTH AND METABOLIC STATE OF THE CORAL ACROPORA-CERVICORNIS, WITH COMMENTS ON METHODS OF NORMALIZATION FOR CORAL DATA', BULLETIN OF MARINE SCIENCE, 33, pp. 336 - 352
Conference Papers
, 2024, 'ASSESSING PATIENT-PERCEIVED BURDEN OF DISEASE IN CROHN'S DISEASE: A NOVEL SCORING APPROACH IN A REAL-WORLD AUSTRALASIAN COHORT', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, DC, Washington, pp. S1444 - S1445, presented at
, 2024, 'ASSESSING PATIENT-PERCEIVED BURDEN OF DISEASE IN ULCERATIVE COLITIS: A NOVEL SCORING APPROACH IN A REAL-WORLD AUSTRALASIAN COHORT', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, DC, Washington, pp. S1444 - S1444, presented at
, 2024, 'DOSE ESCALATED INFLIXIMAB IN INFLAMMATORY BOWEL DISEASE - CROHN'S COLITIS CURE (CCC) DATA INSIGHTS PROGRAM', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, DC, Washington, pp. S1135 - S1135, presented at
, 2024, 'DOSE ESCALATED USTEKINUMAB IN INFLAMMATORY BOWEL DISEASE - CROHN'S COLITIS CURE (CCC) DATA INSIGHTS PROGRAM', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, DC, Washington, pp. S1134 - S1135, presented at
, 2024, 'DOSE ESCALATED VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE - CROHN'S COLITIS CURE (CCC) DATA INSIGHTS PROGRAM', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, DC, Washington, pp. S1135 - S1135, presented at
, 2024, 'IMPROVED CLINICAL AND RADIOLOGIC HEALING OF CROHN'S PERIANAL FISTULAS USING A NOVEL COORDINATED CARE MODEL OPTIMISING MEDICAL AND SURGICAL TREATMENTS: A PROSPECTIVE REAL-WORLD OBSERVATIONAL STUDY', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, DC, Washington, pp. S1126 - S1127, presented at
, 2024, 'THE BURDEN OF MENTAL HEALTH DISEASE IN PEOPLE WITH INFLAMMATORY BOWEL DISEASE - CROHN'S COLITIS CURE (CCC) DATA INSIGHTS PROGRAM', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, DC, Washington, pp. S854 - S855, presented at
, 2024, 'THE REAL-WORLD USE OF FIVE-AMINOSALICYLATE (5ASA) TREATMENT FOR ULCERATIVE COLITIS IN AUSTRALIA AND NEW ZEALAND: CROHN'S COLITIS CURE (CCC) DATA INSIGHT'S PROGRAM', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, DC, Washington, pp. S1456 - S1457, presented at
, 2024, 'TOFACITINIB DEMONSTRATES PRELIMINARY EFFICACY IN INDUCTION OF REMISSION IN CHRONIC POUCHITIS', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, DC, Washington, pp. S216 - S217, presented at
, 2024, 'VARIATION IN OUTCOMES IN INFLAMMATORY BOWEL DISEASE AT TEN AUSTRALASIAN CENTRES - CROHN'S COLITIS CURE (CCC) DATA INSIGHTS PROGRAM', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, DC, Washington, pp. S839 - S839, presented at
, 2023, ' The evolving role of technology in delivering patient-centric care in inflammatory bowel disease - an australasian experience using crohn's colitis care e-health patient portal', in GUT, BMJ PUBLISHING GROUP, PEOPLES R CHINA, Hong Kong, pp. A203 - A203, presented at
, 2023, 'Disease and treatment factors influencing outcomes in fistulising crohn's disease', in GUT, BMJ PUBLISHING GROUP, PEOPLES R CHINA, Hong Kong, pp. A203 - A204, presented at
, 2023, 'Characterisation of hospitalised patients with ulcerative colitis treated with tofacitinib in the OCTAVE clinical programme for up to 7.8 years', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, pp. 678 - 679
, 2021, 'IDDF2021-ABS-0062 A novel decision aid improves knowledge and quality of pregnancy-related decision-making in IBD', in Clinical Gastroenterology, BMJ Publishing Group Ltd and British Society of Gastroenterology, pp. A108.1 - A108, presented at
, 2019, 'Use of a novel tool to identify nutritional risk in an inflammatory bowel disease outpatient service: Liverpool IBD-Nutrition Screen', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 200 - 200, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000483843100314&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2019, 'DELAY IN DIAGNOSIS OF ULCERATIVE COLITIS: RESULTS OF A GLOBAL ULCERATIVE COLITIS NARRATIVE SURVEY', in INFLAMMATORY BOWEL DISEASES, OXFORD UNIV PRESS INC, NV, Las Vegas, pp. S4 - S4, presented at
, 2019, 'PATIENT AND HEALTHCARE PROFESSIONAL VIEWS ON EMOTIONAL HEALTH AND INTIMACY IN ULCERATIVE COLITIS: RESULTS OF A GLOBAL ULCERATIVE COLITIS NARRATIVE SURVEY', in INFLAMMATORY BOWEL DISEASES, OXFORD UNIV PRESS INC, NV, Las Vegas, pp. S12 - S12, presented at
, 2018, 'Genetically distinct signatures of mild and severe ulcerative colitis', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 103 - 104, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000530647800176&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2018, 'Is there a difference in adalimumab drug levels according to pen versus syringe use: An international, multicenter retrospective analysis', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 102 - 102, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000530647800175&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2018, 'YUlcerative Colitis (UC) Narrative Study Australian data: A survey to compare patient and physician perspectives on communication and management of UC', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 105 - 106, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000530647800179&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2018, 'CROHN'S COLITIS CARE (CCCARE) - DEVELOPMENT AND TESTING OF A BESPOKE CLOUD-BASED CLINICAL MANAGEMENT SYSTEM FOR INFLAMMATORY BOWEL DISEASE (IBD)', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, DC, Washington, pp. S892 - S892, presented at
, 2018, 'GENETICALLY DISTINCT SIGNATURES OF MILD AND SEVERE ULCERATIVE COLITIS', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, DC, Washington, pp. S1025 - S1025, presented at
, 2018, 'IN FECAL MICROBIOTA TRANSPLANTATION (FMT) FOR ULCERATIVE COLITIS, FUSOBACTERIUM IS ASSOCIATED WITH LACK OF REMISSION, WHILE METABOLIC SHIFTS TO STARCH DEGRADATION AND SHORT CHAIN FATTY ACID PRODUCTION ARE ASSOCIATED WITH REMISSION - RESULTS FROM THE RANDOMIZED CONTROLLED FOCUS STUDY', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, DC, Washington, pp. S35 - S35, presented at
Filter by type
https://orcid.org/0000-0001-5606-0270